Cargando…
The CHRONICLE Study of US Adults with Subspecialist-Treated Severe Asthma: Objectives, Design, and Initial Results
BACKGROUND: Approximately 5–10% of patients with asthma have severe disease. High-quality real-world studies are needed to identify areas for improved management. OBJECTIVE: Aligned with the International Severe Asthma Registry, the CHRONICLE study (ClinicalTrials.gov: NCT03373045) was developed to...
Autores principales: | Ambrose, Christopher S, Chipps, Bradley E, Moore, Wendy C, Soong, Weily, Trevor, Jennifer, Ledford, Dennis K, Carr, Warner W, Lugogo, Njira, Trudo, Frank, Tran, Trung N, Panettieri, Reynold A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7371434/ https://www.ncbi.nlm.nih.gov/pubmed/32765156 http://dx.doi.org/10.2147/POR.S251120 |
Ejemplares similares
-
Long-Term Use of Maintenance Systemic Corticosteroids is Associated with Multiple Adverse Conditions in a Large, Real-World Cohort of US Adults with Severe Asthma
por: Lugogo, Njira, et al.
Publicado: (2022) -
Impact of the COVID-19 Pandemic on Incidence of Asthma Exacerbations and Hospitalizations in US Subspecialist-Treated Patients with Severe Asthma: Results from the CHRONICLE Study
por: Moore, Wendy C, et al.
Publicado: (2022) -
Health-Related Quality of Life and Productivity Among US Patients with Severe Asthma
por: Soong, Weily, et al.
Publicado: (2021) -
Real World Biologic Use and Switch Patterns in Severe Asthma: Data from the International Severe Asthma Registry and the US CHRONICLE Study
por: Menzies-Gow, Andrew N, et al.
Publicado: (2022) -
Dupilumab Efficacy in Patients with Type 2 Asthma with and without Elevated Blood Neutrophils
por: Bleecker, Eugene R., et al.
Publicado: (2023)